---
title: "Guanethidine - Hypertensive Disorder"
sidebar: mydoc_sidebar
permalink: db01170-mesh-d006973-1.html
toc: false 
---


Path ID: `DB01170_MESH_D006973_1`
{% include image.html url="images/db01170-mesh-d006973-1.png" file="db01170-mesh-d006973-1.png" alt="db01170-mesh-d006973-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D006145 | Guanethidine | Drug |
| UniProt:P23975 | Sodium-dependent noradrenaline transporter | Protein |
| MESH:D009638 | Norepinephrine | ChemicalSubstance |
| GO:0042310 | Vasoconstriction | BiologicalProcess |
| GO:0048243 | Norepinephrine secretion | BiologicalProcess |
| MESH:D006973 | Hypertensive disorder | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Guanethidine | MOLECULARLY INTERACTS WITH | Sodium-Dependent Noradrenaline Transporter |
| Sodium-Dependent Noradrenaline Transporter | DECREASES ABUNDANCE OF | Norepinephrine |
| Norepinephrine | POSITIVELY REGULATES | Vasoconstriction |
| Guanethidine | NEGATIVELY REGULATES | Norepinephrine Secretion |
| Norepinephrine Secretion | POSITIVELY CORRELATED WITH | Norepinephrine |
| Vasoconstriction | POSITIVELY CORRELATED WITH | Hypertensive Disorder |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB01170#BE0000486](https://go.drugbank.com/drugs/DB01170#BE0000486)
  - [https://drugs.ncats.io/drug/5UBY8Y002G](https://drugs.ncats.io/drug/5UBY8Y002G)
